Scott A. Kelly
Overview
Scott A. Kelly received an average of $3M in total compensation, including $627K in salary, at CytoDyn between 2021 and 2022.
Source: SEC filing on October 26, 2022.
Related executives
We found seven more executives who work or worked at CytoDyn.
Nader Pourhassan
CytoDyn
Chief Executive Officer
Chris Recknor
CytoDyn
Sr. Executive VP of Clinical Operations
Antonio Migliarese
CytoDyn
Chief Financial Officer
Nitya Ray
CytoDyn
Chief Technology Officer
Craig Eastwood
CytoDyn
Chief Financial Officer
Michael Mulholland
CytoDyn
Chief Financial Officer
Anthony Caracciolo
CytoDyn